| 1 |
surrender RC letter dated 04.08.2025 (M/s. NKG Advisory Business and Consulting Services Pvt. Ltd) |
2025-Aug-05 |
|
382 KB |
| 2 |
Visitors management FDA Bhawan |
2025-Jul-25 |
|
462 KB |
| 3 |
Issues related to safety of Ranitidine drug due to presence of NDMA impurity |
2025-Jul-24 |
|
71 KB |
| 4 |
CDSCO Visitor Online System |
2025-Jul-24 |
|
600 KB |
| 5 |
Revised Export NOC Guidance document for Manufacture of Unapproved / Approved New Drugs along with Annexures |
2025-Jul-17 |
|
714 KB |
| 6 |
THE SUBJECT EXPERT COMMITTEES GUIDANCE DOCUMENT |
2025-Jul-17 |
|
418 KB |
| 7 |
DCGI Public Hearing Form for applicants |
2025-Jul-07 |
|
563 KB |
| 8 |
Regulatory requirements for outsourcing sterilization activity of medical devices by a manufacturer under Medical Device Rules 2017 |
2025-Jun-24 |
|
713 KB |
| 9 |
Antimicrobial Resistance AMR Mitigation |
2025-Jun-05 |
|
559 KB |
| 10 |
To Share the list of drug products manufacturing permissions issued by State licensing Authority SLA/FDA including antibiotics, FDCs and their premixes for Veterinary use |
2025-Jun-05 |
|
580 KB |
